TY - JOUR T1 - Shocked, relaxed, tired: Mental health during the three waves of the Covid-19 JF - medRxiv DO - 10.1101/2021.07.25.21261094 SP - 2021.07.25.21261094 AU - Jan S. Novotný AU - Juan P. Gonzalez-Rivas AU - Šárka Kunzová AU - Mária Skladaná AU - Anna Pospíšilová AU - Anna Polcrová AU - Maria Vassilaki AU - Jose R. Medina-Inojosa AU - Francisco Lopez-Jimenez AU - Yonas E. Geda AU - Gorazd B. Stokin Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/04/2021.07.25.21261094.abstract N2 - Background Several recent studies reported that the Covid-19 pandemic induces significant mental distress. However, it remains unknown whether mental distress persists or subsides in response to consecutive Covid-19 waves. Therefore, we here examine mental distress before and across the three Covid-19 waves.Methods We measured stress and depressive symptoms prior to and across the three Covid-19 waves in a well-established population-based sample. A total of 330 participants completed e-questionnaires prior to and during the Covid-19 waves. Friedman’s repeated-measures and Wilcoxon rank-sum pairwise test with Bonferroni correction were used to investigate repeated-measure differences, while the Kruskal-Wallis test was used to assess the effect of behavioral and physiological parameters on mental health.Results We found significantly increased mental distress during each of the Covid-19 waves compared with the pre-Covid-19 period. Increased mental distress was more common in women and most pronounced during the 1st and in particular, the 3rd Covid-19 wave. The stress and depressive symptoms increased during the pandemic compared with the pre-Covid-19 period by a maximum of 1.58 and 3.63 times, respectively. Negative emotions and loneliness were identified as the most significant risk factors of Covid-19-induced mental distress, while resilience was found to be protective.Conclusions Mental distress surged during all the Covid-19 waves without showing extinction. This pattern is mechanistically reminiscent of the post-traumatic stress disorder. Our results suggest that the Covid-19 pandemic underlies the development of a novel chronic mental health disorder and do not exclude possible further deterioration of mental health in the case of future Covid-19 waves.Competing Interest StatementMaria Vassilaki has received research funding from Roche and Biogen in the past; she currently consults for Roche, receives research funding from NIH and EU/ St. Anne's University Hospital Brno (Czech Republic), and has equity ownership in Abbott Laboratories, Johnson and Johnson, Medtronic, and Amgen. In addition, she is currently an Associate Editor for the Journal of Alzheimer's Disease and a Guest Editor for the Frontiers Research Topic collection "Multimorbidity in the Context of Neurodegenerative Disorders" (participating journals: Frontiers in Neuroscience-Neurodegeneration and Frontiers in Aging Neuroscience). No other disclosures were reported.Funding StatementSupported by the European Regional Development Fund - Project ENOCH 750 (No. CZ.02.1.01/0.0/0.0/16_019/0000868).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research protocol was approved by St. Anne's University Hospital ethics committee and the Internal Review Board. All participants were acquainted with the research and provided written informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this study are available on request immediately following the publication to anyone who submits the online request that will be approved by the St. Anne's University Hospital International Clinical Research Centre internal board. The researches have to provide their research intentions and goals, and specify, and justify requested variables. The data will be provided for a limited and well-defined time via cloud service or e-mail in csv format. After defined period the data should be returned, and all other copies should be destroyed. ER -